The largest database of trusted experimental protocols

Mir 205 mimic

Manufactured by Qiagen
Sourced in Germany

The MiR-205 mimic is a synthetic RNA molecule designed to mimic the function of the naturally occurring microRNA miR-205. MicroRNAs are small non-coding RNA molecules that play a crucial role in regulating gene expression. The MiR-205 mimic is intended for use in research applications involving the study of miR-205 and its target genes.

Automatically generated - may contain errors

2 protocols using mir 205 mimic

1

IL-32γ and miR-205 Modulation in HaCaT Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HaCaT cells were grown at 378C in Dulbecco modified Eagle medium supplemented with 10% FBS, penicillin (100 U/mL), and streptomycin (100 mg/mL) in a humidified atmosphere of 5% CO 2 . HaCaT cells were transfected with pcDNA3.1(1)-6xMyc-IL-32g vector or control vector by using the Lipofectamine 3000 transfection reagent in Opti-MEM, according to the manufacturer's specifications (Invitrogen, Waltham, Mass). For miR-205 transfection, HaCaT cells were transfected with miR-205 mimic, miR-205 inhibitor, or its controls (Qiagen GmbH, Hilden, Germany) by using Lipofectamine RNAiMAX reagent in Opti-MEM, according to the manufacturer's (Invitrogen) specifications. Transfected cells were stimulated with TNF-a/lFN-g (20 ng/mL; PeproTech Inc, Rocky Hill, NJ) for the indicated time points.
+ Open protocol
+ Expand
2

Modulation of Astrocyte Glucose Response

Check if the same lab product or an alternative is used in the 5 most similar protocols
Astrocytes were cultured in either normal glucose (5 mM) or high glucose (25 mM) DMEM depending upon the experiment. Before transfection, 100,000 to 200,000 astrocytes were seeded in medium size petri dishes (Falcon cat. no. 35046) in 1.5ml of DMEM containing FBS and antibiotics and the appropriate concentration of glucose. Cells were transfected using HiPerfect (Qiagen, Cat. No. 301705) and the fast-forward protocol for transfection of adherent cells recommended by the manufacturer. Astrocytes grown in high glucose DMEM were treated with the miRNA205 inhibitor (Qigaen Cat. No. MIN0000878) or HiPerfect alone (mock-transfected), whereas astrocytes grown in normal glucose DMEM were treated with the miR-205 mimic (Qiagen, Cat. No. MSY0000878) or HiPerfect alone (mock-transfected). Briefly, 10 μl of 20 μM miR-205 inhibitor and 12μL of HiPerfect or 10 μl of 20 μM miR-205 mimic and 24μl of HiPerfect were diluted in 400μL of culture medium without serum. The mix was incubated for 10 minutes at room temperature to allow the formation of transfection complexes. The complexes were then added to the cells in a drop-wise fashion giving a final volume of 2mL and a final concentration of 100nM for the mimic and inhibitor. The plate was gently swirled to evenly distribute the transfection complexes and cells were incubated at 37°C for three days.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!